Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Total Liabilities 2017–2025
Aclaris Therapeutics, Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aclaris Therapeutics, Inc. total liabilities as of December 31, 2025: 57.4M, a 11.42% decrease year-over-year.
- Aclaris Therapeutics, Inc. total liabilities for 2025 were 57.4M, a 11.42% decrease from 2024.
- Aclaris Therapeutics, Inc. total liabilities for 2024 were 64.8M, a 61.02% increase from 2023.
- Aclaris Therapeutics, Inc. total liabilities for 2023 were 40.2M, a 29.40% decrease from 2022.
- Aclaris Therapeutics, Inc. total liabilities for 2022 were 57.0M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aclaris Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $57 |
| 2024 | $65 |
| 2023 | $40 |
| 2022 | $57 |
| 2021 | $54 |
| 2020 | $33 |
| 2019 | $28 |
| 2018 | $60 |
| 2017 | $18 |
Aclaris Therapeutics, Inc. Total Liabilities — FAQ
Aclaris Therapeutics, Inc. (ACRS) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACRS's total liabilities history?
The chart and table above show Aclaris Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.